miltefosine has been researched along with Erysipeloid in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Erysipeloid: An infection caused by Erysipelothrix rhusiopathiae that is almost wholly restricted to persons who in their occupation handle infected fish, shellfish, poultry, or meat. Three forms of this condition exist: a mild localized form manifested by local swelling and redness of the skin; a diffuse form that might present with fever; and a rare systemic form associated with endocarditis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral miltefosine was started at a dose of 150 mg/day but had to be stopped after 20 days as the patient developed diarrhea, bipedal edema, and renal impairment." | 5.56 | Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine. ( Adhikary, S; Karki, A; Parajuli, N; Tiwari, S, 2020) |
| "Oral miltefosine was started at a dose of 150 mg/day but had to be stopped after 20 days as the patient developed diarrhea, bipedal edema, and renal impairment." | 1.56 | Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine. ( Adhikary, S; Karki, A; Parajuli, N; Tiwari, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parajuli, N | 1 |
| Adhikary, S | 1 |
| Karki, A | 1 |
| Tiwari, S | 1 |
1 other study available for miltefosine and Erysipeloid
| Article | Year |
|---|---|
Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine.
Topics: Administration, Oral; Aged; Antibodies, Protozoan; Antiprotozoal Agents; Erysipeloid; Humans; Leishm | 2020 |